The Evidence Base
Post
Peek Behind the Paper: Availability of comparative RWE in Medicare patients – implications for CMS drug price negotiations
In this interview we speak with authors Ashley Jaksa, Market Access Scientific Strategy Lead and Pat Arena, Director, Epidemiology at Ae...
Register with The Evidence Base for free to access this content
Already have an account? Sign in
By registering with The Evidence Base, you will receive our weekly round-up and other relevant editorial content. You can opt-out at any time. View our privacy policy here.